公开(公告)号：US09925153B2

公开(公告)日：2018-03-27

申请号：US15036968

申请日：2014-12-05

Applicant: STC.UNM

Inventor： David L Vander Jagt ,  Lorraine M Deck ,  Robert E Royer ,  John E Heidrich

IPC: A61K31/085 ,  A61K31/12 ,  A61K45/06 ,  A61K31/09 ,  A61K31/121 ,  A61K31/137 ,  A61K31/222 ,  A61K31/4406 ,  A61K31/4409 ,  A61K9/00 ,  A61K31/05 ,  A61K31/136 ,  A61K31/444

CPC classification number: A61K31/12 ,  A61K9/0014 ,  A61K31/05 ,  A61K31/085 ,  A61K31/09 ,  A61K31/121 ,  A61K31/136 ,  A61K31/137 ,  A61K31/222 ,  A61K31/4406 ,  A61K31/4409 ,  A61K31/444 ,  A61K45/06

Abstract: The present invention relates to method(s) of treating a subject afflicted with a skin disease or condition, the method comprising administering to the subject or patient in need a composition comprising a therapeutically effective amount of a substituted cis or trans-stilbene or a stilbene hybrid. A method of treating or reducing the likelihood of a skin disease or condition in a patient is an additional embodiment of the present invention. Preferred pharmaceutical compositions of the invention include nanoemulsions comprising a therapeutically effective amount of a substituted cis or trans-stilbene or stilbene hybrid and at least one antibiotic.